)
Krystal Biotech (KRYS) investor relations material
Krystal Biotech Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Voting matters and shareholder proposals
Election of two Class III directors: Krish S. Krishnan and Christopher Mason, with board recommendation to vote in favor.
Ratification of KPMG LLP as independent registered public accounting firm for fiscal year ending December 31, 2026, recommended for approval.
Advisory approval of named executive officer compensation, with board recommendation to vote in favor.
Approval of Non-Employee Director Compensation Policy, recommended by the board.
Provision for other business to be addressed as may properly come before the meeting.
Board of directors and corporate governance
Nominees for Class III director positions are Krish S. Krishnan and Christopher Mason.
Executive compensation and say-on-pay
Advisory vote on the compensation of named executive officers is included as a proposal.
Separate proposal to approve the Non-Employee Director Compensation Policy.
- Proxy covers director elections, auditor ratification, pay, and new director compensation policy.KRYS
Proxy filing3 Apr 2026 - Strong revenue growth and pipeline progress position the company for major milestones in 2026.KRYS
Corporate presentation16 Mar 2026 - ROW sales and pivotal trial progress position the company for strong 2026 growth.KRYS
TD Cowen 46th Annual Health Care Conference3 Mar 2026 - Record revenue and net income growth, global expansion, and major pipeline progress in 2025.KRYS
Q4 202517 Feb 2026 - Q3 2025 delivered $97.8M revenue, 96% margin, and global VYJUVEK expansion, boosting net income.KRYS
Q3 20253 Feb 2026 - Q2 net product revenue surged 55% to $70.3M, with 91% gross margin and $15.6M net income.KRYS
Q2 20242 Feb 2026 - Strong compliance, broad access, and pipeline advances support robust growth and global expansion.KRYS
Goldman Sachs 45th Annual Global Healthcare Conference1 Feb 2026 - KB301 delivers durable, meaningful wrinkle reduction and is advancing to Phase 2 for décolleté.KRYS
Study Result23 Jan 2026 - Strong U.S. launch, global expansion, and key clinical milestones drive growth outlook.KRYS
2024 Cantor Fitzgerald Global Healthcare Conference20 Jan 2026
Next Krystal Biotech earnings date
Next Krystal Biotech earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Explore our global coverage